Aberrant activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway has been shown to contribute to tumor invasion and progression, and has recently been linked to the EMT process (Reddy et al., 2003; Shin et al., 2010). The gene discussed is WNK2; the disease is neoplasm.